DV
Dividend Vision

EOLS — Evolus Inc

Evolus Inc (EOLS)

Total return is -29.1% over the past 8.5 years, 272.4 points behind SPY at 243.3%. Its deepest 1-year drawdown was 48.7%.

EOLS is an equity fund that tracks Evolus Inc, a single-stock holding established in 2018. The fund holds concentrated exposure to a medical aesthetics company and does not currently pay distributions. With no stated expense ratio or assets under management data available, this fund structure appeals primarily to investors seeking direct equity exposure to Evolus rather than traditional dividend income.

EOLS key facts

Asset type
Stock
Asset class
Equity
Inception date
02/08/2018
Last close
$8.15
Market cap
$377,347,744
Average volume
648700.0
Beta
1.32
Payout ratio
0.0
Forward P/E
52.0833
EPS
$-0.66